Defining psychosis: The evolution of DSM-5 schizophrenia spectrum disorders

Current Psychiatry Reports

Volumn 15, Issue 11, 2013, Pages

  Bhati, Mahendra T ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

DSM; DSM 5; ICD; Psychiatric diagnosis; Psychiatric nosology; Psychiatry; Psychotic disorders; RDoC; Schizophrenia; Schizophrenia spectrum disorders

Indexed keywords

ARTICLE; BRIEF PSYCHOTIC DISORDER; CATATONIA; CONVERGENT VALIDITY; DELUSIONAL DISORDER; DIAGNOSTIC VALUE; DSM-5; FACE VALIDITY; HUMAN; INTERRATER RELIABILITY; MEDICATION INDUCED PSYCHOTIC DISORDER; PSYCHIATRIC DIAGNOSIS; PSYCHOSIS; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SCHIZOPHRENIFORM DISORDER; SCHIZOTYPAL PERSONALITY DISORDER; SYMPTOMATOLOGY; CLASSIFICATION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; PSYCHOTIC DISORDERS; REVIEW;

DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; HUMANS; PSYCHOTIC DISORDERS; SCHIZOPHRENIA;

EID: 84893193295     PISSN: 15233812     EISSN: 15351645     Source Type: Journal    
DOI: 10.1007/s11920-013-0409-9     Document Type: Article

References (31)

1. Ludwig CS, Papyros Ebers: Das hermetische Buch über die Arzeneimittel der alten Ägypter in hieratischer Schrift, herausgegeben mit Inhaltsangabe und Einleitung versehen von Georg Ebers, mit Hieroglyphisch- Lateinischem Glossar von Ludwig Stern, mit Unterstützung des Königlich Sächsischen Cultusministerium (in German), G. Ebers, Editor 1875.
2. Tandon R. Schizophrenia and other Psychotic Disorders in DSM-5. Clin Schizophr Relat Psychoses. 2013;7:16-9.
3. Clegg JW. Teaching about mental health and illness through the history of the DSM. Hist Psychol. 2012;15:364-70.
4. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5). Washington, DC: American Psychiatric Association; 2013.
5. KimY. Historical perspective of PTSD and future revision inDSM-5. Seishin Shinkeigaku Zasshi. 2012;114:1031-6.
6. Matsunaga H. Current and emerging features of obsessivecompulsive disorder-trends for the revision of DSM-5. Seishin Shinkeigaku Zasshi. 2012;114:1023-30.
7. Hyman SE. Can neuroscience be integrated into the DSM-V? Nat Rev Neurosci. 2007;8:725-32. (Pubitemid 47283150)
8. Palmer RH, Button TM, Rhee SH, et al. Genetic etiology of the common liability to drug dependence: evidence of common and specific mechanisms for DSM-IV dependence symptoms. Drug Alcohol Depend. 2012;123 Suppl 1:S24-32.
9. Phelps J, Ghaemi SN. The mistaken claim of bipolar 'overdiagnosis': solving the false positives problem for DSM-5/ICD-11. Acta Psychiatr Scand. 2012;126:395-401.
10. Spitzer RL, Forman JB, Nee J. DSM-III field trials: I. Initial interrater diagnostic reliability. Am J Psychiatry. 1979;136:815-7. (Pubitemid 9206097)
11. Clarke DE, Narrow WE, Regier DA, et al. DSM-5 field trials in the United States and Canada, Part I: study design, sampling strategy, implementation, and analytic approaches. Am J Psychiatry. 2013;170: 43-58.
12. Adityanjee, Aderibigbe YA, Theodoridis D, et al. Dementia praecox to schizophrenia: the first 100 years. Psychiatry Clin Neurosci. 1999;53:437-48. (Pubitemid 29404164)
13. Berrios GE. Eugen Bleuler's place in the history of psychiatry. Schizophr Bull. 2011;37:1095-8.
14. Schneider K. Clinical psychopathology. New York: Grune and Stratton; 1959.
15. Nordgaard J, Arnfred SM, Handest P, et al. The diagnostic status of first-rank symptoms. Schizophr Bull. 2008;34:137-54. (Pubitemid 350262279)
16. Adam D. Mental health: on the spectrum. Nature. 2013;496:416-8.
17. Kupfer DJ, Kuhl EA, Regier DA. DSM-5-the future arrived. JAMA. 2013;309:1691-2.
18. Tsuang MT, Stone WS, Faraone SV. Toward reformulating the diagnosis of schizophrenia. Am J Psychiatry. 2000;157:1041-50. (Pubitemid 30432482)
19. Regier DA, Narrow WE, Clarke DE, et al. DSM-5 field trials in the United States and Canada, Part II: test-retest reliability of selected categorical diagnoses. Am J Psychiatry. 2013;170:59-70.
20. Handest P, Parnas J. Clinical characteristics of first-admitted patients with ICD-10 schizotypal disorder. Br J Psychiatry Suppl. 2005;48:s49-54. (Pubitemid 41139666)
21. Tandon R, GaebelW, Barch DM, et al.: Definition and description of schizophrenia in the DSM-5. Schizophr Res 2013.
22. Tsuang MT, Van Os J, Tandon R, et al. Attenuated psychosis syndrome in DSM-5. Schizophr Res. 2013. doi:10.1016/j.schres.2013.05.004.
23. Hendrickx L, Gijs L, Enzlin P. Distress, sexual dysfunctions, and DSM: dialogue at cross purposes? J Sex Med. 2013;10:630-41.
24. Narrow WE, Clarke DE, Kuramoto SJ, et al. DSM-5 field trials in the United States and Canada, Part III: development and reliability testing of a cross-cutting symptom assessment for DSM-5. Am J Psychiatry. 2013;170:71-82.
25. Kraemer HC, Kupfer DJ, NarrowWE, et al.Moving toward DSM-5: the field trials. Am J Psychiatry. 2010;167:1158-60.
26. Kraemer HC, Kupfer DJ, Clarke DE, et al. DSM-5: how reliable is reliable enough. Am J Psychiatry. 2012;169:13-5.
27. NIMH Research Domain Criteria (RDoC). Available from: http://www.nimh.nih.gov/research-priorities/rdoc/nimh-research-domain-criteria- rdoc.shtml.
28. Schmeck K, Schluter-Muller S, Foelsch PA, et al. The role of identity in the DSM-5 classification of personality disorders. Child Adolesc Psychiatr Ment Health. 2013;7:27.
29. Stein DJ, Lund C, Nesse RM. Classification systems in psychiatry: diagnosis and global mental health in the era of DSM-5 and ICD-11. Curr Opin Psychiatr. 2013;26:493-7.
30. Andrews G, Goldberg DP, Krueger RF, et al. Exploring the feasibility of a meta-structure for DSM-Vand ICD-11: could it improve utility and validity? Psychol Med. 2009;39:1993-2000.
31. Kendell R, Jablensky A. Distinguishing between the validity and utility of psychiatric diagnoses. Am J Psychiatry. 2003;160:4-12. (Pubitemid 36042419)